Skip to content

Bruno Pereira Dos Santos

Universidade Federal de Ciências da Saúde de Porto Alegre

2 papers in the library · publishing 2026

Papers

Evaluation of Neurotoxicity of NBOH Derivatives

Pharmaceuticals July 8, 2026 Rodrigo Foss da Silva, Lennon Machado Alves, Fernanda Conte et al.

NBOHs, a class of new psychoactive substances acting on serotonin receptors, show varying neurotoxicity. In human neuron-like cells, two derivatives, 25E-NBOH and 25B-NBOH, reduced cell viability, caused mitochondrial hyperpolarization, and increased oxidative species. In fruit flies, 25B-NBOH impaired climbing ability, and both 25E-NBOH and 25B-NBOH elevated catalase and acetylcholinesterase enzyme activities at 50 nM. These results suggest that 25E- and 25B-NBOH are more toxic than 25I-NBOH, with potential mechanisms involving mitochondrial signaling, oxidative stress, and cholinergic disruption.

Shifting Patterns in Ecstasy Use: Increasing Detection of MDA in Forensic Seizures and Toxicological Cases in Southern Brazil

Journal of Psychoactive Drugs June 10, 2026 Bruno Pereira Dos Santos, Vítor Camargo Pôrto, Letícia Birk et al.

In Brazil, ecstasy-type drugs are the most commonly seized synthetic drugs, and recent years have seen a shift from MDMA to its analog MDA, possibly due to changes in synthetic routes during the COVID-19 pandemic. Analysis of drug seizures in Rio Grande do Sul found MDA in 31.1% of samples, surpassing MDMA at 25.6%, with MDA detections peaking at 52.6% in 2023. Clinical and forensic cases also showed MDA predominating from 2021 onward. This higher prevalence of MDA indicates a change in ecstasy use patterns, highlighting the need for robust analytical methods and ongoing toxicological monitoring to inform drug surveillance and public health policies.